We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.30 | 3.20 | 3.40 | 3.30 | 3.30 | 3.30 | 63,406 | 07:49:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.26 | 2.98M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/9/2020 15:08 | wow, 171k sell! | jusjusjus | |
21/9/2020 14:59 | 40p is just about GBP 25m market cap.With 4 cancer drugs in development and a combination treatment for covid 19 that's a low market cap especially when compared to other similar companies on the market. | jungmana | |
21/9/2020 14:09 | They’ve only got 50k so far will need to go higher to right the balance maybe 30p | 412069 | |
21/9/2020 13:56 | They have now found the price which attracts some sells. Why sell at this stage, well, if held since sub 10p, why not derisk. Nothing in life is certain. I think 40p is ambitious before results. BWTFDIK my portfolio is all over the place today without much rational. | stoneme | |
21/9/2020 13:54 | roger, not after Suzys tweet pumps off nothing this is awaiting some very good news. | 412069 | |
21/9/2020 13:50 | Imho, market cap is ridiculous , long way to go to. Cash in bank and good compounds that hopefully will make a difference for people suffering cancer and endometriosis. Recently a good BOD that treat shareholders with respect. | jassyb55 | |
21/9/2020 13:46 | From lse in case anyone not seen: Suzy Dilly RetweetedShareBuyers 'Chart with upwards trendGoing for growth! With ValiRx #VAL shares soaring over 300% and clinical trial results due in Q3 from a lead program, we discuss growth plans with CEO Dr Suzanne Dilly as it readies to enter a new era' | joeblogg2 | |
21/9/2020 13:45 | We deserve at least 40p before the news. When good news lands hopefully next week , expect 100p+ in quick time. | jungmana | |
21/9/2020 13:44 | Oi oi. Looks like a leak on Val 201.Pj | reidy66 | |
21/9/2020 13:36 | There are no sellers however high they take it. Time for another shake? It will not work. I think we will see 30p today or tomorrow. | stoneme | |
21/9/2020 13:33 | May rise up to 30p towards the close today, with a Mcap of still only £16m. | 412069 | |
21/9/2020 13:27 | nobody here selling nico! | jusjusjus | |
21/9/2020 13:21 | Why would anyone sell here when 201 is valued at nothing ? And if could be a cure for cancer ?Our peers are valued at 4 x us Crazy mkt capShould be at least 25m mkt cap so 40p ..minimum | nico115 | |
21/9/2020 13:18 | NT to buy now. | 412069 | |
21/9/2020 13:09 | 68.5k @ 26p! | jusjusjus | |
21/9/2020 12:52 | No sellers about hence the rise off Suzys tweet today. | 412069 | |
21/9/2020 12:49 | still waiting...as it keeps rising lmao | nmulm | |
21/9/2020 12:44 | Who would want to sell now when our Uni tie ups will be worth the mkt cap and everything else in for nowt | nico115 | |
21/9/2020 12:41 | JS... still looking for his 3p entry ha. | 412069 | |
21/9/2020 12:39 | solid buying since 12:00! | jusjusjus | |
21/9/2020 12:19 | I can hear that herd coming, be quick when this moves it moves very fast, could open x 2-3 on morning of the rns. | 412069 | |
21/9/2020 12:17 | Thanks for flagging up the Twitter & LinkedIn posts 412069 & JasonPugh. Interesting indeed, share price now moving into positive territory... | lagansider | |
21/9/2020 12:15 | Looking like 201's coming in good. | 412069 | |
21/9/2020 12:06 | Suzy has released info on LinkedIn.Well done Suzy. Yet again your communications with shareholders is five star. This is only going up as NPV is at least 3 times Mcap on 201 potential alone! She sounds very very confident! DYOR | jasonpugh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions